Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Healthcare
Zenas BioPharma, Inc. Revenue 2023–2025
Zenas BioPharma, Inc. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zenas BioPharma, Inc. revenue for the quarter ending September 30, 2025 was 0.
- Zenas BioPharma, Inc. revenue for the twelve months ending September 30, 2025 was 10.0 M.
- Zenas BioPharma, Inc. annual revenue for 2025 was 10.0 M, a 100.00% increase from 2024.
- Zenas BioPharma, Inc. annual revenue for 2024 was 5.0 M, a 90.00% decrease from 2023.
- Zenas BioPharma, Inc. annual revenue for 2023 was 50.0 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zenas BioPharma, Inc. Market Cap — FAQ
Zenas BioPharma, Inc. (ZBIO) market cap over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZBIO's market cap history?
The chart and table above show Zenas BioPharma, Inc.'s market cap by year and by quarter, including the growth rate.